Background
==========

*Cryptococcus neoformans* (*C. neoformans*) is an encapsulated yeast which causes life-threatening infections in immunocompromised individuals, especially in patients with AIDS who are often unable to eliminate cryptococci completely from the cerebrospinal fluid (CSF) in an advanced stage of disease \[[@B1]-[@B3]\]. Cryptococcosis primarily affects these patients, but recently it has also been observed in immunocompetent individuals \[[@B4]-[@B8]\]. *C. neoformans* can be found worldwide particularly in bird guano, or in guano-contaminated soil. Upon inhalation of spores or yeast cells, it causes pulmonary infections. From the lung *C. neoformans* can disseminate into the skin and to the brain \[[@B9]\]. There it presents as meningoencephalitis or meningitis, which is fatal without antifungal therapy. The polysaccharide capsule is one of the most potent virulence factors of cryptococci and can inhibit phagocytosis \[[@B10]\]. After phagocytosis *C. neoformans* can survive and replicate in the acidic environment of the phagosome by increasing the pH \[[@B11]\].

Microglia, the resident phagocytes of the central nervous system (CNS), together with perivascular and meningeal macrophages constitute the first line of defense of the brain tissue in CNS infections \[[@B12],[@B13]\]. In the resting state, they are scanning the CNS parenchyma by means of motile processes and will be activated when the microenvironment is changed. Microglial cells express Toll-like receptors (TLRs) which can identify pathogen-associated molecular patterns (PAMPs) and thereby play an important role as regulators of the innate immune response \[[@B14],[@B15]\]. While bacterial lipoproteins and zymosan, a component of *Saccharomyces cerevisiae* (*S. cerevsiae*), are recognized by TLR2, lipopolysaccharide (LPS) from Gram-negative bacteria and glucuronoxylomannan, the major capsular polysaccharide of *C. neoformans*, are ligands of TLR4, and bacterial and also fungal DNA activates TLR9 \[[@B16]-[@B19]\]. Upon TLR stimulation, the ability of microglia to phagocytose Gram-positive and Gram-negative bacteria is increased \[[@B20],[@B21]\]. We hypothesized that this mechanism could be a therapeutic option in fungal CNS infections. Therefore, we studied the phagocytosis of *C. neoformans* by microglial cells after TLR stimulation.

Materials and methods
=====================

Primary mouse microglial cell cultures
--------------------------------------

Primary mixed glial cultures were prepared from brains of newborn wild-type C57BL/6 mice (postnatal day 0, p0-p2), or myeloid differentiation factor (MyD)88-deficient mice (p0-p2) with the same genetic background \[[@B22]\]. After removal of the meninges, cells were treated with trypsin (Sigma-Aldrich, Taufkirchen, Germany) for 10 minutes to isolate the cells, and afterwards with DNAse (Sigma-Aldrich). After centrifugation cells were suspended in DMEM (Gibco, Karlsruhe, Germany) supplemented with 10% heat-inactivated FCS, 100 U/ml penicillin and 100 μg/ml streptomycin. Cells were plated at a density of two brains per T75 culture flask (Corning Costar, Wiesbaden, Germany) and incubated at 37°C with 5% CO~2~. After 10 to 14 days, microglial cells were isolated from the confluent astrocyte layer by shaking 200 times/minute for 30 minutes and plated in 96-well plates at a density of 50,000 cells per well.

Microglia stimulation with TLR agonists Pam~3~CSK~4~, poly (I:C), LPS and CpG
-----------------------------------------------------------------------------

Microglial cells from wild-type C57BL/6 and Myd88-deficient mice were exposed for 24 h to 0.1 μg/ml tripalmitoyl-S-glyceryl-cystein (Pam~3~CSK~4~; 910.5 Da; EMC Microcollections; Tübingen,Germany), 0.01 μg/ml LPS from *Escherichia coli* (*E. coli*) serotype O26:B6 (Sigma-Aldrich) or 1 μg/ml CPG oligodesoxynucleotide (ODN) 1668 (TCC ATG ACG TTG CTG ATG CT; molecular mass 6,383 Da, TIB Molbiol, Berlin, Germany), for TLR1/2, 4 and 9 stimulation, respectively. In experiments with MyD88-deficient mice, microglia were also exposed to 30 μg/ml of the TLR3 agonist polyinosine-polycytidylic acid (poly (I:C), 1.5 to 8 kb, InvivoGen, San Diego, CA, USA). TLR agonists were used at the lowest concentration that induced maximum stimulation as assessed by nitric oxide production \[[@B23]\]. A control group with unstimulated microglial cells was included in all experiments. For the measurement of cytokine release, supernatants from microglial cells stimulated for 24 h were collected and kept frozen at −20°C until assaying.

Yeast strains and culture conditions
------------------------------------

The encapsulated *C. neoformans* strain 11959 (ATCC 90112) was cultured in YPG medium (1% yeast extract,1% peptone, 2% glucose) at 30°C for 2 days. The cell suspension was mixed with glycerine and kept at −80°C. In each experiment, *C. neoformans* from the glycerine stock was grown on Sabouraud agar plates at 37°C. Colonies from the Sabouraud agar plate were resuspended in DMEM and counted in a Neubauer-hemocytometer to determine the concentration of fungi in the inoculum.

Phagocytosis assay
------------------

After stimulation, microglial cells from either C57BL/6 wild-type or MyD88-deficient mice were co-incubated with the encapsulated *C. neoformans* resuspended in DMEM for 120 minutes at a number of 6 × 10^6^ colony-forming units (CFU)/well, with a ratio of approximately 120 yeast cells per phagocyte. After co-incubation with *C. neoformans*, microglial cells were washed with PBS and incubated with DMEM containing amphotericin B (2.5 μg/ml, Sigma-Aldrich) for 1 h to kill extracellular cryptococci. We confirmed amphotericin B activity by plating supernatants of each experiment after 1 h of incubation with amphotericin B. Thereafter, microglial cells were washed twice with PBS and lysed with distilled water. The ingested *C. neoformans* CFU were counted by quantitative plating of serial 1:10 dilutions on Sabouraud agar plates.

Intracellular survival assay
----------------------------

TLR-stimulated or unstimulated microglial cells from wild-type C57BL/6 mice were incubated with *C. neoformans* for 120 minutes. Thereafter, cells were washed with PBS and incubated in DMEM containing amphotericin B (2.5 μg/ml) for up to 3 h to kill extracellular cryptococci. At different time points (60, 120 and 180 minutes), cells were washed with PBS and lysed with distilled water. The intracellular cryptococci were counted by quantitative plating of serial 1:10 dilutions on Sabouraud agar plates.

Cytokine measurements
---------------------

TNF-α, chemokine (C-X-C motif) ligand 1 (CXCL1) (also KC, or growth-regulated oncogene α (GROα)), IL-6, IL-10 and macrophage inflammatory protein (MIP)-2 were used to characterize microglial activation. DuoSet ELISA development kits (R&D Systems, Wiesbaden, Germany) were used for the cytokine measurements. The color reaction was quantified at 450 nm on a microplate reader (Bio-Rad, Munich, Germany).

Measurement of cell viability
-----------------------------

To measure the metabolic activity of viable cells, the WST-1 cell proliferation reagent (Roche Applied Science, Mannheim, Germany) was used. Microglial cells were incubated with 2.5 μg/ml amphotericin B for 3 h. Thereafter microglial cells were incubated with WST-1 for 3 h. Then, the produced formazan salt was measured by an increase of the optical density at 490 nm using a Genios multiplate reader (Tecan, Crailsheim, Germany). After 3 h of incubation, there was no toxic effect of amphotericin B on microglial cell viability (data not shown).

Statistics
----------

Statistical analysis and graphical presentation was performed by using GraphPad Prism 5 Software (GraphPad Software, San Diego, CA, USA). Data were expressed as the median with the 25% and 75% interquartile range, and were compared using the Kruskal-Wallis test followed by Dunn's multiple comparison test for selected columns to correct for repeated testing. *P* \<0.05 was considered statistically significant.

Results
=======

Stimulation with Pam~3~CSK~4~, LPS or CpG increased the phagocytosis of *C. neoformans* by microglial cells
-----------------------------------------------------------------------------------------------------------

The phagocytic rates of *C. neoformans* after 120 minutes of phagocytosis are shown in Figure [1](#F1){ref-type="fig"}. The number of intracellular cryptococci found in unstimulated microglia (12844 ± 6608 CFU/well expressed as mean ± SD) was considered to be 100%. Unstimulated cells ingested cryptococci at a lower rate compared to cells stimulated with TLR agonists. Pre-stimulation of microglial cells with different TLR agonists caused an increase in the uptake of cryptococci. Pre-stimulation with 0.1 μg/ml Pam~3~CSK~4~ and 0.01 μg/ml LPS increased the phagocytic rate approximately 15-fold (*P* \<0.001) and 19-fold (*P* \<0.001), respectively. The phagocytic rate after pre-stimulation with 1 μg/ml CpG was increased more than 36-fold (*P* \<0.001). Additionally, we tested the extracellular amphotericin B activity in the cell culture medium after 1 h of incubation with amphotericin B by plating supernatants. The number of CFU was below the level of detection (10 CFU/ml) in each experiment.

![**Phagocytosis of*C. neoformans*by unstimulated and stimulated microglial cells.** Microglia were either unstimulated or stimulated with Pam~3~CSK~4~ 0.1 μg/ml, lipopolysaccharide (LPS) 0.01 μg/ml or CpG 1 μg/ml for 24 h (n ≥20 wells/group from five independent experiments). In each experiment, the mean number of bacteria ingested by the control group was considered to be 100%. Phagocytic rates of the stimulated groups are presented as percentages of phagocytosis by the unstimulated control group. Data are given as medians with interquartile ranges. Data were analyzed by Kruskal-Wallis test followed by Dunn's multiple comparison test to correct for repeated testing; ^\*\*\*^*P*\<0.001.](1742-2094-10-71-1){#F1}

Enhanced phagocytosis required a functional MyD88 signaling cascade
-------------------------------------------------------------------

Microglial cells from C57BL/6 wt and MyD88-deficient mice were stimulated with 0.1 μg/ml Pam~3~CSK~4~, 30 μg/ml poly (I:C), 0.01 μg/ml LPS and 1 μg/ml CpG. Phagocytosed cryptococci (CFU/well) were converted into percentage, and the median number of intracellular cryptococci found in unstimulated wild-type C57Bl/6 cells was considered to be 100% (Figure [2](#F2){ref-type="fig"}). Unstimulated MyD88-deficient microglia tended to phagocytose lower amounts of cryptococci than their wild-type counterpart (*P*-value not significant). After Pam~3~CSK~4,~ poly (I:C), LPS and CpG stimulation, MyD88-deficient microglial cells also had reduced ability to phagocytose *C. neoformans* compared to their wild-type counterparts (*P* \<0.05 for Pam~3~CSK~4,~*P* \<0.01 for LPS, and *P* \< 0.01 for CpG)~.~ The highest phagocytic rate of MyD88-deficient cells compared to the wild-type cells was seen after poly (I:C) stimulation (*P*-value not significant).

![**Phagocytic rates of*C. neoformans*in stimulated wild**-**type and MyD88**-**deficient microglial cells after 120 minutes of phagocytosis.** Microglia were either unstimulated or stimulated with Pam~3~CSK~4~ 0.1 μg/ml, polyinosine-polycytidylic acid (poly (I:C)) 30 μg/ml, lipopolysaccharide (LPS) 0.01 μg/ml or CpG 1 μg/ml for 24 h. Phagocytosed cryptococci (colony-forming units (CFU)/well) were converted into percentage, and the median number of intracellular cryptococci from wild-type cells was considered to be 100% (n ≥12 wells/group from three independent experiments). Data are given as medians with interquartile ranges. Data were analyzed by Kruskal-Wallis test followed by Dunn's multiple comparison test to correct for repeated testing; ^\*^*P* \<0.05, ^\*\*^*P* \<0.01; n.s., not significant; wt, wild-type.](1742-2094-10-71-2){#F2}

Intracellular killing of *Cryptococcus neoformans* was enhanced after stimulation with Pam~3~CSK~4~, LPS and CpG
----------------------------------------------------------------------------------------------------------------

The absolute numbers of intracellularly killed cryptococci after 3 h were higher in microglial cells after 24 h of Pam~3~CSK~4,~ LPS and CpG stimulation than in unstimulated cells. The median number of cryptococci killed by TLR-stimulated microglial cells was 53,000 CFU/well (Pam~3~CSK~4~), 14,750 CFU/well (LPS) and 92,000 CFU/well (CpG) compared to 8,300 CFU/well by unstimulated microglial cells (Figure [3](#F3){ref-type="fig"}). Stimulation of microglia with Pam~3~CSK~4~ or CpG resulted in significantly higher intracellular killing of cryptococci in comparison to unstimulated cells (*P* \<0.05).

![**Intracellular killing of*C. neoformans*by unstimulated and Toll-like receptor (TLR)**-**stimulated microglial C57BL**/**6 cells.** Intracellular killing was expressed as the number of cryptococci (median with interquartile ranges) recovered at the different time points (n ≥8 wells/group from two independent experiments). The absolute numbers of cryptococci killed after 3 h were higher in Pam~3~CSK~4~- and CpG-stimulated microglia than in unstimulated microglial cells; ^\*^*P* \<0.05.](1742-2094-10-71-3){#F3}

Stimulation of microglia by TLR agonists induced TNF- α, CXCL1, IL-6, Il-10 and MIP-2 release
---------------------------------------------------------------------------------------------

To confirm microglial activation by the TLR agonists, we measured the concentration of TNF-α, CXCL1, IL-6, IL-10 and MIP-2 in the supernatants of microglial cultures after stimulation with Pam~3~CSK~4~, LPS and CpG (Figure [4](#F4){ref-type="fig"}). The limit of detection was 15 pg/ml for TNF-α, 62 pg/ml for CXCL1 and 31 pg/ml for IL-6, IL-10 and MIP-2. In the supernatants of unstimulated microglial cells after 24 h the median cytokine concentrations were below the detection limit for all cytokines and chemokines. Microglial stimulation with 0.1 μg/ml Pam~3~CSK~4~, 0.01 μg/ml LPS and 1 μg/ml CpG induced the release of high amounts of TNF-α, CXCL1, IL-6, IL-10 and MIP-2. Except for the IL-10 release after Pam~3~CSK~4~ stimulation, for all TLR agonists versus the control group the *P*-value was \<0.05.

![**Cytokine and Chemokine release of unstimulated and stimulated microglial cells.** Tumor necrosis factor (TNF)-α (**A**), chemokine (C-X-C motif) ligand 1 (CXCL1) (**B**), macrophage inflammatory protein (MIP)-2 (**C**), interleukin (IL)-6 (**D**) and IL-10 (**E**) concentrations (in pg/ml) in the supernatant of microglial cell cultures after 24 h of stimulation with 0.1 μg/ml Pam~3~CSK~4~, 0.01 μg/ml lipopolysaccharide (LPS) and 1 μg/ml CpG. Data are given as medians with interquartile ranges. Data were analyzed by Kruskal-Wallis test followed by Dunn's multiple comparison test to correct for repeated testing; ^\*^*P* \<0.05, ^\*\*^*P* \<0.01, ^\*\*\*^*P* \<0.001.](1742-2094-10-71-4){#F4}

Discussion
==========

Current antifungal treatment of cryptococcal meningitis consists of amphotericin B plus flucytosine followed by fluconazole for a long period of time \[[@B24]\]. In clinical practice, AIDS patients show a reduced response to amphotericin B and flucytosine and often need lifelong prevention of relapses with fluconazole. For these immunocompromised individuals it would be highly beneficial to identify new therapeutic approaches helping the host to eliminate cryptococci from the CNS.

*In vitro* experiments have demonstrated that phagocytosis is dependent on the influence of opsonins \[[@B25]\]. TLRs play a crucial role in recognition of PAMPs and the pathogen-triggered inflammatory response \[[@B26]\]. We found that stimulation of microglial cells by different TLR agonists significantly increased the phagocytosis of fungi (present data) and bacteria \[[@B20],[@B21]\]. This suggests that stimulation of microglial cells enhances the cellular innate immune response thereby increasing phagocytosis of invading bacteria or fungi and acts as an endogenous protective factor of the brain and myelon. The adaptor protein MyD88 is involved in the signaling cascade leading to the activation of nuclear factor-κB. All TLRs except TLR3 use the MyD88-dependent pathway. A mediator of the MyD88-independent pathway is the adaptor, TIR-domain-containing adapter-inducing interferon-β (TRIF), which relays signals of TLR3 and TLR4 \[[@B15]\]. We have shown that the increase of phagocytosis of *C. neoformans* by the different TLR agonists requires the functional MyD88 signaling cascade. After stimulation with Pam~3~CSK~4,~ LPS and CpG, the phagocytic rate of MyD88-deficient microglial cells was strongly diminished compared to wild-type microglia. Conversely the difference of phagocytosed cryptococci was not significant different in poly (I:C)-stimulated wild-type and MyD88-deficient microglia.

Intracellular survival, expulsion of the yeast by phagocytic cells, intracellular replication and cell-to-cell spread of *C. neoformans* play an important role in the pathogenesis of infection in immunosupressed patients \[[@B27],[@B28]\]. Conversely, macrophages can phagocytose and kill *C. neoformans* in immunocompetent individuals \[[@B29]\]. When studying intracellular survival, intracellular replication of *C. neoformans* is a very important issue that has to be considered. It has been observed that cryptococci replicate faster intracellularly than extracellularly \[[@B30],[@B31]\]. In our intracellular survival experiment over 3 h, we found a decrease of intracellular cryptococci in microglial cells and a higher absolute number of *C. neoformans* killed in Pam~3~CSK~4~-~,~ LPS- and CpG-stimulated microglial cells compared to unstimulated cells. Extracellular amphotericin B was necessary for the whole incubation time to avoid migration of viable cryptococci from the interior of the microglial cells to the medium, and subsequent extracellular growth. Microglia activated by TLR agonists produce proinflammatory cytokines (for example, TNF-α, IL-1 and IL-6) and nitric oxide, which can cause neuronal injury \[[@B32]-[@B36]\]. For this reason, the approach described here will have to be tested *in vivo* for efficacy and with respect to the possible induction of unintended neuronal injury. It may be necessary to design milder strategies for microglial activation in order to increase the infection resistance of the CNS without causing neuronal injury. In conclusion, our results suggest that the administration of TLR agonists is of potential therapeutic interest in the prevention and adjunctive treatment of *C. neoformans* meningitis and meningoencephalitis in high-risk groups such as patients with AIDS, or organ transplant recipients.
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